This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Sep;Suppl(Suppl):S47-62.

doi: 10.1136/gut.32.suppl.s47.

Viral hepatitis

J Y Lau¹, G J Alexander, A Alberti

Affiliations

PMID: 1916470
PMCID: PMC1405217
DOI: 10.1136/gut.32.suppl.s47

Review

Viral hepatitis

J Y Lau et al. Gut. 1991 Sep.

. 1991 Sep;Suppl(Suppl):S47-62.

doi: 10.1136/gut.32.suppl.s47.

Authors

J Y Lau¹, G J Alexander, A Alberti

Affiliation

¹ Royal Free Hospital School of Medicine, London.

PMID: 1916470
PMCID: PMC1405217
DOI: 10.1136/gut.32.suppl.s47

No abstract available

PubMed Disclaimer

Similar articles

Serologic markers of hepatitis B virus infection.
Hoofnagle JH, Schafer DF. Hoofnagle JH, et al. Semin Liver Dis. 1986 Feb;6(1):1-10. doi: 10.1055/s-2008-1040787. Semin Liver Dis. 1986. PMID: 3086979 Review. No abstract available.
[New recommendations for diagnosis and virological monitoring of viral hepatitis].
Pol S. Pol S. Gastroenterol Clin Biol. 2003 Jan;27(1):89. Gastroenterol Clin Biol. 2003. PMID: 12594370 French. No abstract available.
[Virus-host relations in hepatitis infections].
Frei PC. Frei PC. Z Gesamte Inn Med. 1986 Sep 1;41(17):473-5. Z Gesamte Inn Med. 1986. PMID: 2431549 German.
Hepatitis B: virology, epidemiology, disease, and prevention, and an overview of viral hepatitis.
Moyer LA, Mast EE. Moyer LA, et al. Am J Prev Med. 1994;10 Suppl:45-55. Am J Prev Med. 1994. PMID: 7841006 Review. No abstract available.
The agents of human viral hepatitis, and control of the disease.
Deinhardt F. Deinhardt F. Prog Med Virol. 1984;30:14-28. Prog Med Virol. 1984. PMID: 6087411 Review. No abstract available.

See all similar articles

Cited by

Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus.
Ndeboko B, Omouessi ST, Ongali B, Mouinga-Ondémé A. Ndeboko B, et al. Pharmaceuticals (Basel). 2020 Dec 21;13(12):483. doi: 10.3390/ph13120483. Pharmaceuticals (Basel). 2020. PMID: 33371278 Free PMC article. Review.
Risks and benefits of interferon-alpha in the treatment of hepatitis.
Pardo M, Marriott E, Moliner MC, Quiroga JA, Carreño V. Pardo M, et al. Drug Saf. 1995 Nov;13(5):304-16. doi: 10.2165/00002018-199513050-00004. Drug Saf. 1995. PMID: 8785018 Review.
Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.
Fang JW, Wu PC, Lai CL, Lo CK, Meager A, Lau JY. Fang JW, et al. Dig Dis Sci. 1994 Sep;39(9):2014-21. doi: 10.1007/BF02088140. Dig Dis Sci. 1994. PMID: 8082512

References

1. J Virol. 1986 Dec;60(3):880-7 - PubMed
1. Science. 1986 Apr 25;232(4749):477-84 - PubMed
1. Br Med Bull. 1990 Apr;46(2):423-41 - PubMed
1. Science. 1990 Mar 16;247(4948):1335-9 - PubMed
1. Proc Natl Acad Sci U S A. 1990 Feb;87(3):983-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources